The Business Journals26d
Organogenesis signs Smithfield lease with subsidies in hand
In addition to wound care products, Organogenesis is advancing an injected treatment called RENEW for painful knee osteoarthritis. On the risk side, the company has said it could see market ...
CNN4y
Organogenesis Holdings, Inc. Class A
Organogenesis Holdings, Inc. is a regenerative medical company, which engages in the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical and ...
Barclays PLC Has $271,000 Position in Organogenesis Holdings Inc. (NASDAQ:ORGO)
Barclays PLC boosted its holdings in Organogenesis Holdings Inc. (NASDAQ:ORGO – Free Report) by 251.7% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange ...
Organogenesis Holdings Inc. (NASDAQ:ORGO) Sees Significant Increase in Short Interest
Organogenesis Holdings Inc. (NASDAQ:ORGO – Get Free Report) saw a significant increase in short interest in the month of December. As of December 15th, there was short interest totalling 11,000,000 ...
The Boston Globe26d
A Massachusetts biotech firm will expand to Rhode Island, receive nearly $20 million in incentives from the state
PROVIDENCE — Rhode Island Commerce Corporation has granted Organogenesis, a Massachusetts biotech firm, more than $13 million in tax incentives, to support the company’s opening of a new ...